We are live on ! Find out more
HFCIV

H&F Corporate Investors VIII Portfolio holdings

AUM $133M
1-Year Est. Return 24.42%
This Fund
S&P 500
This Quarter Est. Return
+43.89%
1 Year Est. Return
-24.42%
3 Year Est. Return
-33.78%
5 Year Est. Return
-50.35%
10 Year Est. Return
AUM
$4.62B
AUM Growth
+$1.32B
Cap. Flow
$0
Cap. Flow %
0%
Top 10 Hldgs %
100%
Holding
2
New
Increased
Reduced
Closed

Top Buys

No buys this quarter

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PPD
1
DELISTED
PPD, Inc. Common Stock
PPD
$2.57B 55.59%
55,722,731
CTEV
2
Claritev Corp
CTEV
$652M
$2.05B 44.41%
5,387,862

Similar funds

H&F Corporate Investors VIII's Q2 2021 Portfolio in Review

As of Q2 2021, H&F Corporate Investors VIII held 2 positions worth $4.62B, up 40% from $3.3B the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Trading was light in Q2 2021: portfolio turnover was 0%. H&F Corporate Investors VIII opened no new positions and made no exits, leaving the 2-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • H&F Corporate Investors VIII's ten largest holdings make up 100% of its $4.62B portfolio in Q2 2021.
  • H&F Corporate Investors VIII opened 0 new positions and closed 0 in Q2 2021.
  • H&F Corporate Investors VIII's portfolio value rose 40% quarter-over-quarter to $4.62B.

Based on H&F Corporate Investors VIII's 13F filing for Q2 2021, filed 13 Aug 2021.